1 study found for:    19560810 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Biological: Golimumab 50 mg;   Biological: Golimumab 100 mg

Indicates status has not been verified in more than two years